Astrazeneca (AZN) EBIT (2009 - 2026)
Astrazeneca's EBIT was $3.16 billion in Q2 2026, down 9.8% from $3.51 billion a year earlier and down 25.5% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EBIT (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Astrazeneca's EBIT was $13.97 billion through Jun 30, 2026, up 23.4% year-over-year; for FY2025, it came in at $13.74 billion, up 37.4% from FY2024.
- EBIT has now increased for four consecutive years, with a five-year compound annual growth rate of 21.6% (FY2020 to FY2025).
- In earlier years, EBIT was $10 billion in FY2024 (+22.1%), $8.19 billion in FY2023 (+118.1%), $3.76 billion in FY2022 (+255.8%) and $1.06 billion in FY2021 (-79.5%).
- Quarterly EBIT has moved between -$1.67 billion (Q3 2021) and $4.25 billion (Q1 2026) over five years.
- Compared with a year earlier, EBIT was higher in seven of the last eight quarters, with growth averaging 30.1%.
- The best year-over-year quarter for EBIT over five years was Q2 2023 (growth of 355.7%); the worst was Q1 2022 (a decline of 53.7%).
- Per Business Quant data, AZN's EBIT in the three quarters before Q2 2026 was $4.25 billion (Q1 2026), $2.98 billion (Q4 2025) and $3.58 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 360.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.16 Bn |
| Mar 31, 2026 | 4.25 Bn |
| Dec 31, 2025 | 2.98 Bn |
| Sep 30, 2025 | 3.58 Bn |
| Jun 30, 2025 | 3.51 Bn |
| Mar 31, 2025 | 3.67 Bn |
| Dec 31, 2024 | 2.04 Bn |
| Sep 30, 2024 | 2.11 Bn |
| Jun 30, 2024 | 2.75 Bn |
| Mar 31, 2024 | 3.12 Bn |
| Dec 31, 2023 | 1.23 Bn |
| Sep 30, 2023 | 1.95 Bn |
| Jun 30, 2023 | 2.46 Bn |
| Mar 31, 2023 | 2.55 Bn |
| Dec 31, 2022 | 1.09 Bn |
| Sep 30, 2022 | 1.25 Bn |
| Jun 30, 2022 | 539.00 Mn |
| Mar 31, 2022 | 878.00 Mn |
| Dec 31, 2021 | -292.00 Mn |
| Sep 30, 2021 | -1.67 Bn |
API Access
Astrazeneca EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();